Maria Mancini
Chief Operating Officer en CHAMPIONS ONCOLOGY, INC. .
Perfil
Maria Mancini is currently the Chief Operating Officer at Champions Oncology, Inc. She previously worked as the Research Director at Biomodels LLC from 2011 to 2015.
Dr. Mancini holds a doctorate degree from the University of Maine.
Cargos activos de Maria Mancini
Empresas | Cargo | Inicio |
---|---|---|
CHAMPIONS ONCOLOGY, INC. | Chief Operating Officer | - |
Antiguos cargos conocidos de Maria Mancini.
Empresas | Cargo | Fin |
---|---|---|
Biomodels LLC
Biomodels LLC BiotechnologyHealth Technology Biomodels LLC offers customized solutions for the development of disease models in the fields of biology, behavior, and neuroscience. Biomodels is based in Boston, MA and was founded in 1997 with the aim of creating a more useful interface between leading academic researchers and the pharmaceutical industry. The private company provides a wide range of behavioral tests for examining treatment for neurological disorders. The company has developed several models of fibrosis to reflect common inflammatory diseases. The company also offers in vitro models for drug response assessment, metabolic disease studies, microbiome research services, and preclinical research services for cancer, radiation countermeasures, and inflammatory diseases. | Chief Tech/Sci/R&D Officer | 01/03/2015 |
Formación de Maria Mancini.
University of Maine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHAMPIONS ONCOLOGY, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Biomodels LLC
Biomodels LLC BiotechnologyHealth Technology Biomodels LLC offers customized solutions for the development of disease models in the fields of biology, behavior, and neuroscience. Biomodels is based in Boston, MA and was founded in 1997 with the aim of creating a more useful interface between leading academic researchers and the pharmaceutical industry. The private company provides a wide range of behavioral tests for examining treatment for neurological disorders. The company has developed several models of fibrosis to reflect common inflammatory diseases. The company also offers in vitro models for drug response assessment, metabolic disease studies, microbiome research services, and preclinical research services for cancer, radiation countermeasures, and inflammatory diseases. | Health Technology |
- Bolsa de valores
- Insiders
- Maria Mancini